Ezio Bonvini - Feb 22, 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Sr VP, Research & CSO
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Stock symbol
MGNX
Transactions as of
Feb 22, 2023
Transactions value $
-$23,704
Form type
4
Date filed
2/24/2023, 03:34 PM
Previous filing
Feb 17, 2023
Next filing
Dec 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $0 +9.38K +8.19% $0.00 124K Feb 22, 2023 Direct F1
transaction MGNX Common Stock Tax liability -$23.7K -3.62K -2.92% $6.55 120K Feb 22, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -9.38K -100% $0.00* 0 Feb 22, 2023 Common Stock 9.38K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.